NYSEARCA:CCEL - NYSE Arca - US2288951088 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to CCEL. CCEL was compared to 103 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of CCEL while its profitability can be described as average. CCEL has a expensive valuation and it also scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -0.27% | ||
ROE | N/A | ||
ROIC | 7.06% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 11.93% | ||
PM (TTM) | N/A | ||
GM | 76.23% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 1.42 | ||
Altman-Z | 0.06 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.6 | ||
Quick Ratio | 0.57 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 6.68 | ||
EV/EBITDA | 8.01 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 17.99% |
NYSEARCA:CCEL (7/28/2025, 8:13:24 PM)
4.92
-0.08 (-1.65%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 17.99% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 1.24 | ||
P/FCF | 6.68 | ||
P/OCF | 6.34 | ||
P/B | N/A | ||
P/tB | N/A | ||
EV/EBITDA | 8.01 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -0.27% | ||
ROE | N/A | ||
ROCE | 8.94% | ||
ROIC | 7.06% | ||
ROICexc | 7.88% | ||
ROICexgc | 8.51% | ||
OM | 11.93% | ||
PM (TTM) | N/A | ||
GM | 76.23% | ||
FCFM | 18.56% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 1.42 | ||
Debt/EBITDA | 1.65 | ||
Cap/Depr | 26.99% | ||
Cap/Sales | 1% | ||
Interest Coverage | 1.89 | ||
Cash Conversion | 125.21% | ||
Profit Quality | N/A | ||
Current Ratio | 0.6 | ||
Quick Ratio | 0.57 | ||
Altman-Z | 0.06 |